Requip

In the US, Requip (ropinirole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder and Restless Legs Syndrome.

US matches:

• Requip


• Requip XL Extended-Release Tablets


• Requip Starter Kit


• Requip XL


• Requip-XL

UK matches:

• Requip Tablets (SPC)
• Requip XL prolonged-release tablets (SPC)

Ingredient matches for Requip

Ropinirole

Ropinirole is reported as an ingredient of Requip in the following countries:

• Slovenia


• Taiwan


• Tunisia

Ropinirole hydrochloride (a derivative of Ropinirole) is reported as an ingredient of Requip in the following countries:

• Argentina


• Austria


• Belgium


• Brazil


• Bulgaria


• Canada


• Chile


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Estonia


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Japan


• Latvia


• Luxembourg


• Malaysia


• Malta


• Netherlands


• New Zealand


• Norway


• Oman


• Poland


• Portugal


• Romania


• Serbia


• Singapore


• Slovakia


• South Africa


• Spain


• Sweden


• Switzerland


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.